Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03900442
Title Phase 1 Study of PTX-100 in Patients With Advanced Malignancies
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Prescient Therapeutics, Ltd.
Indications

multiple myeloma

pancreatic cancer

peripheral T-cell lymphoma

primary cutaneous T-cell non-Hodgkin lymphoma

colorectal cancer

diffuse gastric cancer

angioimmunoblastic T-cell lymphoma

Therapies

GGTI-2418

Age Groups: adult | senior
Covered Countries


No variant requirements are available.